HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 257 filers reported holding HERBALIFE LTD in Q4 2020. The put-call ratio across all filers is 2.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,335,248 | +3.1% | 95,443 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $1,294,964 | -1.8% | 97,807 | +19.5% | 0.00% | 0.0% |
| Q1 2023 | $1,318,107 | +8.2% | 81,870 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,217,898 | -27.2% | 81,848 | -2.7% | 0.00% | -50.0% |
| Q3 2022 | $1,673,000 | -0.9% | 84,149 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $1,689,000 | -37.9% | 82,581 | -7.8% | 0.00% | 0.0% |
| Q1 2022 | $2,719,000 | -20.2% | 89,567 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $3,407,000 | -20.3% | 83,248 | -17.5% | 0.00% | 0.0% |
| Q3 2021 | $4,275,000 | -21.4% | 100,892 | -1.5% | 0.00% | -33.3% |
| Q2 2021 | $5,442,000 | -0.1% | 102,381 | -16.6% | 0.00% | 0.0% |
| Q1 2021 | $5,445,000 | +0.4% | 122,765 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $5,423,000 | +37.1% | 112,874 | +33.1% | 0.00% | +50.0% |
| Q3 2020 | $3,955,000 | +14.8% | 84,778 | +10.7% | 0.00% | 0.0% |
| Q2 2020 | $3,445,000 | -16.3% | 76,563 | -45.8% | 0.00% | -50.0% |
| Q1 2020 | $4,117,000 | -24.5% | 141,199 | +23.4% | 0.00% | 0.0% |
| Q4 2019 | $5,452,000 | +33.8% | 114,381 | +6.3% | 0.00% | 0.0% |
| Q3 2019 | $4,074,000 | -98.6% | 107,602 | -98.4% | 0.00% | -98.4% |
| Q2 2019 | $281,194,000 | +79.8% | 6,576,081 | +122.8% | 0.25% | +75.4% |
| Q1 2019 | $156,399,000 | -23.8% | 2,951,455 | -15.2% | 0.14% | -33.3% |
| Q4 2018 | $205,223,000 | +24.7% | 3,481,292 | +15.4% | 0.21% | +44.9% |
| Q3 2018 | $164,541,000 | -8.3% | 3,016,300 | -9.7% | 0.15% | -16.5% |
| Q2 2018 | $179,354,000 | -31.0% | 3,338,675 | +25.3% | 0.18% | -27.3% |
| Q1 2018 | $259,761,000 | +0.9% | 2,665,027 | -29.9% | 0.24% | +5.2% |
| Q4 2017 | $257,375,000 | -14.2% | 3,800,583 | -14.0% | 0.23% | -21.0% |
| Q3 2017 | $299,867,000 | -4.6% | 4,420,858 | +0.3% | 0.29% | -4.9% |
| Q2 2017 | $314,367,000 | +10.2% | 4,407,218 | -10.2% | 0.31% | +19.1% |
| Q1 2017 | $285,193,000 | +23.2% | 4,905,251 | +2.0% | 0.26% | +11.3% |
| Q4 2016 | $231,456,000 | -18.1% | 4,807,961 | +5.5% | 0.23% | -13.8% |
| Q3 2016 | $282,483,000 | +7.3% | 4,556,907 | +1.3% | 0.27% | -8.2% |
| Q2 2016 | $263,254,000 | -17.7% | 4,497,768 | -13.4% | 0.29% | -24.2% |
| Q1 2016 | $319,885,000 | +60.5% | 5,196,314 | +39.8% | 0.38% | +68.1% |
| Q4 2015 | $199,352,000 | +11.2% | 3,717,860 | +13.0% | 0.23% | +6.5% |
| Q3 2015 | $179,335,000 | +21.7% | 3,290,537 | +23.0% | 0.22% | +49.3% |
| Q2 2015 | $147,409,000 | -37.3% | 2,675,779 | -7.7% | 0.14% | -39.2% |
| Q1 2015 | $235,135,000 | -19.0% | 2,898,652 | -32.0% | 0.24% | -8.1% |
| Q4 2014 | $290,468,000 | +129.0% | 4,260,257 | +46.9% | 0.26% | +150.5% |
| Q3 2014 | $126,845,000 | -14.3% | 2,899,328 | +26.4% | 0.10% | -14.9% |
| Q2 2014 | $148,008,000 | +21.6% | 2,293,293 | +7.9% | 0.12% | +1.7% |
| Q1 2014 | $121,720,000 | +225.4% | 2,125,359 | +347.2% | 0.12% | +240.0% |
| Q4 2013 | $37,402,000 | -8.6% | 475,251 | -18.9% | 0.04% | -14.6% |
| Q3 2013 | $40,910,000 | +100.4% | 586,363 | +29.7% | 0.04% | +95.2% |
| Q2 2013 | $20,413,000 | +30.1% | 452,233 | +8.0% | 0.02% | +31.2% |
| Q1 2013 | $15,686,000 | – | 418,880 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |